ArticleScientific reports2016

Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potential.

Jason J Lohmueller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.